๐ฐ Castro News
Page 82 - Castro News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Castro. Real-time updates on events, politics, business and more.
May 10, 2023
About three weeks after Moonbin's passing, ASTRO fans, AROHAs, protested against Fantagio for allegedly ignoring the late idol's health complaint in the past. #ASTRO #Moonbin #Fantagio
May 8, 2023
CORALVILLE, Iowa, May 8, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual ESTRO Congress
May 7, 2023
Light from satellites competes with celestial displays in remote Western Australia's dark starry skies.
May 7, 2023
These are the horoscopes for week commencing May 8, 2023. Aries 21 March – 20 April A surprising offer could come out of the blue, and you may be delighte...
May 6, 2023
George Springer homered and Chris Bassitt pitched seven shutout innings as the visiting Toronto Blue Jays ended a five-game losing streak by beating the Pittsbu
May 5, 2023
Why the $100,000 cost for one tiny home isnโt the main hold-up on a new project in the Mission District meant to help address homelessness in SF.
May 4, 2023
A low-pressure system continues to spin near California, creating a rinse-and-repeat pattern of showers and gloomy conditions across the Bay Area.
May 3, 2023
Horoscope Today, May 3, 2023: Taurus Must Not Lend Money, Leo Will Get Success -- aaa
May 3, 2023
Sutro Biopharma (NASDAQ:STRO – Get Rating) and Brookline Capital Acquisition (NASDAQ:BCAC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. Valuation & Earnings This table compares Sutro Biopharma […]
May 2, 2023
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Rating) have received an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month […]